Content area

|
|

Udredning af thyroideaincidentalomer påvist ved 18F-fluordeoxyglukose-PET/CT

Forfattere
Ali Asmar1, Lene Simonsen1, Jens Bülow1, 2 & Meena Asmar1, 3 1) Klinisk Fysiologisk og Nuklearmedicinsk Afdeling, Bispebjerg Hospital 2) Biomedicinsk Institut, Københavns Universitet 3) Endokrinologisk Afdeling, Bispebjerg Hospital Ugeskr Læger 2017;179:V12160893
Reference: 
Ugeskr Læger 2017;179:V12160893
Blad nummer: 
Sidetal: 
2-6
Workup of thyroid incidentalomas identified by 18F-fluorodeoxyglucose PET/CT
Several reports have described dramatic increase over recent decades in the incidence of thyroid cancer, even as thyroid cancer-related mortality rates have not changed substantially. Nevertheless, in several retrospective studies the incidence of malignancy in focal 18F-fluorodeoxyglucose (FDG) thyroid uptake discovered on whole body 18F-FDG PET/CT, carried out for non-thyroid cancers, is 13-64%. Our aim was to design a practical algorithm for management of an increasing number of thyroid incidentalomas, identified by 18F-FDG PET/CT.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Tine Bodil Houmann | 15/07
37 kommentarer
af Klaus Roelsgaard | 15/07
2 kommentarer
af Geske Johanne Glahn | 14/07
1 Kommentar
af Finn Redke | 14/07
4 kommentarer
af Finn Redke | 14/07
3 kommentarer
af Peter Henrik Andersen | 10/07
1 Kommentar
af Anette Bendiksen | 09/07
1 Kommentar